Jasper Therapeutics (JSPR) Institutional Ownership $21.57 +0.04 (+0.19%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)CurrentInstitutional OwnershipPercentage79.85%Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$66.32MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$751.01M Get JSPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data JSPR Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Jasper Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024 Franklin Resources Inc.579,636$10.90M0.0%-17.0%3.864% 11/19/2024 Barclays PLC16,146$304K0.0%+320.7%0.108% 11/16/2024 Geode Capital Management LLC257,416$4.84M0.0%-0.9%1.704% 11/15/2024 Barclays PLC16,146$304K0.0%+320.7%0.107% 11/15/2024 Jane Street Group LLC13,354$251K0.0%N/A0.088% 11/15/2024 Wellington Management Group LLP23,759$447K0.0%N/A0.157% Get the Latest News and Ratings for JSPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp214,883$4.04M0.0%+12.3%1.423% 11/15/2024 Samsara BioCapital LLC584,642$11.00M2.1%+11.4%3.872% 11/15/2024 Ikarian Capital LLC55,175$1.04M0.1%-47.5%0.365% 11/14/2024 Braidwell LP483,300$9.09M0.3%N/A3.201% 11/14/2024 Verition Fund Management LLC25,353$477K0.0%N/A0.168% 11/14/2024 Ally Bridge Group NY LLC399,466$7.51M4.0%+82.7%2.645% 11/14/2024 MetLife Investment Management LLC6,874$129K0.0%+129.1%0.046% 11/13/2024 Great Point Partners LLC322,380$6.06M1.8%-19.8%2.135% 11/13/2024 BNP Paribas Financial Markets2,512$47K0.0%+208.6%0.017% 11/13/2024 FMR LLC38,361$722K0.0%N/A0.254% 10/30/2024 AlphaCentric Advisors LLC17,500$329K0.2%N/A0.116% 10/29/2024 Fernwood Investment Management LLC52,897$995K0.3%+6.9%0.351% 10/16/2024 Wolff Wiese Magana LLC3,146$59K0.0%N/A0.021% 8/14/2024 Great Point Partners LLC402,015$9.13M1.7%-1.4%2.669% 8/14/2024 Ally Bridge Group NY LLC218,614$4.96M3.0%-24.6%1.451% 8/8/2024 American Century Companies Inc.14,204$322K0.0%+27.1%0.094% 8/1/2024 Rhumbline Advisers13,231$300K0.0%N/A0.088% 7/26/2024 Bank of New York Mellon Corp32,579$740K0.0%N/A0.216% 5/29/2024 Opaleye Management Inc.435,573$12.79M2.8%-89.1%2.892% 5/20/2024 Virtu Financial LLC10,410$306K0.0%N/A0.069% 5/17/2024 Ikarian Capital LLC105,175$3.09M0.3%N/A0.698% 5/16/2024 Kingdon Capital Management L.L.C.497,000$14.59M1.6%-86.0%3.300% 5/14/2024 Qiming U.S. Ventures Management LLC928,964$27.27M30.4%-89.1%6.168% 5/14/2024 StemPoint Capital LP129,211$3.79M1.0%N/A0.858% 5/10/2024 Vanguard Group Inc.612,745$17.99M0.0%-85.0%4.069% 5/8/2024 Russell Investments Group Ltd.79,811$2.34M0.0%N/A0.530% 5/7/2024 Concurrent Investment Advisors LLC20,409$599K0.0%N/A0.136% 5/3/2024 Carlyle Group Inc.1,066,189$31.30M2.0%-87.8%7.080% 3/18/2024 Kingdon Capital Management L.L.C.3,540,000$2.79M0.3%+16.4%31.720% 2/15/2024 Opaleye Management Inc.3,985,340$3.14M0.8%N/A35.717% 2/7/2024 Ieq Capital LLC54,500$43K0.0%N/A0.488% 2/7/2024 Monaco Asset Management SAM249,563$197K0.1%N/A2.236% 2/5/2024 Fernwood Investment Management LLC494,706$390K0.1%+8.8%4.433% 11/13/2023 Mariner LLC652,749$457K0.0%-8.7%0.589% Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown.11/9/2023 Cowen AND Company LLC200,393$140K0.0%N/A0.181% 11/8/2023 Forefront Analytics LLC110,792$78K0.0%+59.7%0.100% 10/30/2023 Summit Trail Advisors LLC65,000$46K0.0%N/A0.059% 8/15/2023 Sphera Funds Management LTD.4,274,008$5.86M0.9%+5.7%3.874% 8/14/2023Jefferies Financial Group Inc.489,884$671K0.0%N/A0.444% 6/1/2023 Prelude Capital Management LLC54,500$99K0.0%N/A0.049% 5/16/2023 Ally Bridge Group NY LLC2,517,232$4.56M6.0%N/A2.301% 5/16/2023 BVF Inc. IL9,900,000$17.92M0.7%N/A9.051% 5/15/2023 Affinity Asset Advisors LLC476,948$863K0.3%N/A0.436% 5/15/2023 Kingdon Capital Management L.L.C.3,040,000$5.50M1.0%+463.0%2.779% 5/15/2023 RTW Investments LP2,329,809$4.22M0.1%N/A2.130% 5/12/2023 Forefront Analytics LLC30,290$55K0.0%-73.4%0.028% 5/5/2023 Carlyle Group Inc.8,761,891$15.77M0.5%N/A8.011% 5/3/2023 Jump Financial LLC33,074$60K0.0%N/A0.030% 4/25/2023 Qiming U.S. Ventures Management LLC8,519,648$15.42M18.7%+45.6%7.789% 2/13/2023 Forefront Analytics LLC114,000$55K0.0%-4.8%0.300% 2/7/2023 Fernwood Investment Management LLC454,706$220K0.1%+53.1%1.197% 11/14/2022 Forefront Analytics LLC119,800$94K0.1%+246.0%0.327% 11/9/2022 Fernwood Investment Management LLC297,080$234K0.1%N/A0.810% 5/10/2022 Sectoral Asset Management Inc.675,000$2.40M0.4%N/A1.782% 5/9/2022 Forefront Analytics LLC32,550$118K0.0%N/A0.086% 4/27/2022Vahanian & Associates Financial Planning Inc.10,000$36K0.1%-60.0%0.026% 2/15/2022 Kingdon Capital Management L.L.C.540,000$4.24M0.5%N/A1.427% 2/2/2022Grace Capital218,110$1.71M1.0%N/A0.576% 1/28/2022Vahanian & Associates Financial Planning Inc.25,000$196K0.2%N/A0.066% 11/16/2021 Citadel Advisors LLC3,005,035$29.22M0.0%N/A8.228% 11/15/2021 Tudor Investment Corp Et Al20,000$205K0.0%N/A0.055% 11/15/2021Abingworth LLP5,628,558$58.03M13.2%N/A15.412% (Data available from 1/1/2016 forward) JSPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of JSPR shares? During the previous two years, 43 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Carlyle Group Inc. ($31.30M), Qiming U.S. Ventures Management LLC ($27.27M), Vanguard Group Inc. ($17.99M), BVF Inc. IL ($17.92M), Kingdon Capital Management L.L.C. ($14.59M), Opaleye Management Inc. ($12.79M), and Samsara BioCapital LLC ($11.00M).Learn more on JSPR's institutional investors. What percentage of Jasper Therapeutics stock is owned by institutional investors? 79.85% of Jasper Therapeutics stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings. Which institutional investors have been buying Jasper Therapeutics stock? Of the 38 institutional investors that purchased Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($9.90M), Carlyle Group Inc. ($8.76M), Opaleye Management Inc. ($3.99M), Kingdon Capital Management L.L.C. ($3M), Ally Bridge Group NY LLC ($2.70M), Qiming U.S. Ventures Management LLC ($2.67M), and RTW Investments LP ($2.33M). How much institutional buying is happening at Jasper Therapeutics? Institutional investors have bought a total of 36,550,154 shares in the last 24 months. This purchase volume represents approximately $608.33M in transactions. Which Jasper Therapeutics major shareholders have been selling company stock? Of the 12 institutional investors that sold Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Carlyle Group Inc. ($7.70M), Qiming U.S. Ventures Management LLC ($7.59M), Opaleye Management Inc. ($3.55M), Vanguard Group Inc. ($3.48M), Kingdon Capital Management L.L.C. ($3.04M), Franklin Resources Inc. ($118.90K), and Forefront Analytics LLC ($89.51K). How much institutional selling is happening at Jasper Therapeutics? Institutional investors have sold a total of 25,838,860 shares in the last 24 months. This volume of shares sold represents approximately $752.99M in transactions. Related Companies Spyre Therapeutics Major Shareholders Calliditas Therapeutics AB (publ) Major Shareholders ARS Pharmaceuticals Major Shareholders Syndax Pharmaceuticals Major Shareholders ANI Pharmaceuticals Major Shareholders Rocket Pharmaceuticals Major Shareholders Bicycle Therapeutics Major Shareholders Avadel Pharmaceuticals Major Shareholders Collegium Pharmaceutical Major Shareholders Bicara Therapeutics Major Shareholders This page (NASDAQ:JSPR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JSPR Stock Alerts